Fig. 3

Proportion of patients with comorbid conditions for biologic and non-biologic users. Clinical characteristics were measured on the earliest CRSwNP diagnosis date during the study identification period. In addition to the comorbid conditions shown, significantly more biologic users had respiratory infections than non-biologic users. COPD, chronic obstructive pulmonary disease; CRSwNP, chronic rhinosinusitis with nasal polyps; EGPA, eosinophilic granulomatosis with polyangiitis; GERD, gastroesophageal reflux disease